Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al

Lene Ringholm; Nicoline Callesen Do; Peter Damm; Elisabeth Reinhardt Mathiesen

doi:10.1007/s00592-022-01996-8

Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al

Lene Ringholm^*, Nicoline Callesen Do, Peter Damm, Elisabeth Reinhardt Mathiesen

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › Research › peer-review

1 Citation (Scopus)

Original language	English
Journal	Acta Diabetologica
Volume	60
Issue number	1
Pages (from-to)	141-142
Number of pages	2
ISSN	0940-5429
DOIs	https://doi.org/10.1007/s00592-022-01996-8
Publication status	Published - 2023

Access to Document

10.1007/s00592-022-01996-8

Cite this

@article{774e8d5e3107473aa0329586aa52fe2e,

title = "Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al",

author = "Lene Ringholm and Do, {Nicoline Callesen} and Peter Damm and Mathiesen, {Elisabeth Reinhardt}",

note = "Funding Information: ERM has received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation. Funding Information: L. Ringholm has received a research grant from Novo Nordisk (Grant number: U1111-1209-6358) for an investigator-sponsored study. ",

year = "2023",

doi = "10.1007/s00592-022-01996-8",

language = "English",

volume = "60",

pages = "141--142",

journal = "Acta Diabetologica",

issn = "0940-5429",

publisher = "Springer",

number = "1",

}

TY - JOUR

T1 - Pregnancy outcomes in women with type 1 diabetes using insulin degludec

T2 - response to Kamran et al

AU - Ringholm, Lene

AU - Do, Nicoline Callesen

AU - Damm, Peter

AU - Mathiesen, Elisabeth Reinhardt

N1 - Funding Information: ERM has received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation. Funding Information: L. Ringholm has received a research grant from Novo Nordisk (Grant number: U1111-1209-6358) for an investigator-sponsored study.

PY - 2023

Y1 - 2023

U2 - 10.1007/s00592-022-01996-8

DO - 10.1007/s00592-022-01996-8

M3 - Comment/debate

C2 - 36283987

AN - SCOPUS:85141061788

VL - 60

SP - 141

EP - 142

JO - Acta Diabetologica

JF - Acta Diabetologica

SN - 0940-5429

IS - 1

ER -